Development of a validated liquid chromatographic method for determination of related substances of telmisartan in bulk drugs and formulations

Journal of Pharmaceutical and Biomedical Analysis

Volumn 56, Issue 3, 2011, Pages 471-478

  Nageswara Rao, R ^a   Guru Prasad, K ^a   Gangu Naidu, C ^a   Maurya, Pawan K ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Bulk drugs; Hypertension; Related substances; RP HPLC; Telmisartan

Indexed keywords

ACETONITRILE; AMMONIUM ACETATE; TELMISARTAN; TRIETHYLAMINE; TRIFLUOROACETIC ACID;

ARTICLE; DRUG IMPURITY; DRUG SYNTHESIS; LIMIT OF DETECTION; PH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE; TABLET FORMULATION;

ACETONITRILES; BENZIMIDAZOLES; BENZOATES; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, LIQUID; DRUG CONTAMINATION; ETHYLAMINES; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; TABLETS;

EID: 79961128641     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.05.043     Document Type: Article

References (30)

1. Ruth R.W., William J.C., John D.I., Michael R.C., Kristine P., Ronald D.S., Pieter B.M.W.M.T. Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy. J. Med. Chem. 1996, 39:625-656.
2. Uwe J.R., Gerhard B.N., Kai M.H., Helmut W., Michael E., Jacobus C.A., Van M., Wolfgang W., Norbert H.H. 6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships. J. Med. Chem. 1993, 36:4040-4051.
3. Merlos M., Casas A. Castaner, telmisartan, antihypertensive, angiotensin II antagonist. J. Drugs Future 1997, 22:1112-1116.
4. Reddy K.S., Srinivasan N., Reddy C.R., Kolla N., Anjaneyulu Y., Venkatraman S., Bhattacharya A., Mathad V.T. An efficient and impurity-free process for telmisartan: an antihypertensive drug. Org. Process Res. Dev. 2007, 11:81-85.
5. Zhang H., Jiang Y.Y., Wen J., Zhou T.T., Fan G.R., Wu Y.T. Rapid determination of telmisartan in human plasma by HPLC using a monolithic column with fluorescence detection and its application to a bioequivalence study. J. Chromatogr. B 2009, 877:3729-3733.
6. Brunetto M.R., Contreras Y., Clavijo S., Torres D., Delgado Y., Ovalles F., Ayala C., Gallignani M., Estela J.M., Martin V.C. Determination of losartan, telmisartan, and valsartan by direct injection of human urine into a column-switching liquid chromatographic system with fluorescence detection. J. Pharm. Biomed. Anal. 2009, 50:194-199.
7. Shen Y.L., Feng F., Wu J. Evaluation of HPLC-fluorescence and LC-ESI/MS for determination of telmisartan in human plasma. Yaowu Fenxi Zazhi 2006, 26:71-75.
8. Torrealday N., Gonzalez L., Alonso R.M., Jimenez R.M., Ortiz Lastra E. Experimental design approach for the optimization of a HPLC-fluorimetric method for the quantitation of the angiotensin II receptor antagonist telmisartan in urine. J. Pharm. Biomed. Anal. 2003, 32:847-857.
9. Nie J., Zhao Q., Huang J.F., Xiang B.R., Feng Y.Q. Determination of telmisartan in rat tissues by in-tube solid-phase microextraction coupled to high performance liquid chromatography. J. Sep. Sci. 2008, 31:667-676.
10. Nie J., Zhang M., Fan Y., Wen Y., Xiang B.G., Feng Y.Q. Biocompatible in-tube solid-phase microextraction coupled to HPLC for the determination of angiotensin II receptor antagonists in human plasma and urine. J. Chromatogr. B 2005, 828:62-69.
11. Ferreiros N., Iriarte G., Alonso R.M., Jimenez R.M., Ortiz E. Separation and quantitation of several angiotensin II receptor antagonist drugs in human urine by a SPE-HPLC-DAD method. J. Sep. Sci. 2006, 29:650-655.
12. Yan T.T., Li H., Deng L.L., Guo Y.J., Yu W.S., Fawcett J.P., Zhang D., Cui Y.M., Gu J.K. Liquid chromatographic-tandem mass spectrometric method for the simultaneous quantitation of telmisartan and hydrochlorothiazide in human plasma. J. Pharm. Biomed. Anal. 2008, 48:1225-1229.
13. Zhu X.Y., Sun J.G., Hao H.P., Wang G.J., Hu X.L., Lv H., Gu S.H., Wu X.M., Xu J.Y. Simultaneous determination of multiple angiotensin type 1 receptor antagonists and its application to high-throughput pharmacokinetic study: cassette dosing versus cassette analysis. Int. J. Mass Spectrom. 2008, 272:127-136.
14. Ferreiros N., Dresen S., Alonso R.M., Weinmann W. Validated quantitation of angiotensin II receptor antagonists (ARA-II) in human plasma by liquid-chromatography-tandem mass spectrometry using minimum sample clean-up and investigation of ion suppression. Ther. Drug Monit. 2007, 29:824-834.
15. Li P.F., Wang Y.W., Wang Y., Tang Y.B., Fawcett J.P., Cui Y.M., Gu J.K. Determination of telmisartan in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2005, 828:126-129.
16. Chen B.M., Liang Y.Z., Wang Y.L., Deng F.L., Zhou P., Guo F.Q., Huang L.F. Development and validation of lF human plasma. Anal. Chim. Acta 2005, 540:367-373.
17. Zhang H., Fang Y.Z. HPLC/APCI-MS determination of telmisartan in human plasma. Yaowu Fenxi Zazhi 2004, 24:497-499.
18. Griessner M., Broeker P., Lehmann A., Ehrentreich-Foerster E., Bier F.F. Detection of angiotensin II type 1 receptor ligands by a cell-based assay. Anal. Bioanal. Chem. 2009, 395:1937-1940.
19. Hempen C., Glaesle-Schwarz L., Kunz U., Karst U. Determination of telmisartan in human blood plasma. Part I. Immunoassay development. Anal. Chim. Acta 2006, 560:35-40.
20. Hempen C., Glaesle-Schwarz L., Kunz U., Karst U. Determination of telmisartan in human blood plasma. Part II. Liquid chromatography-tandem mass spectrometry method development, comparison to immunoassay and pharmacokinetic study. Anal. Chim. Acta 2006, 560:41-49.
21. Zhang M., Wei F., Zhang Y.F., Nie J., Feng Y.Q. Novel polymer monolith microextraction using a poly(methacrylic acid-ethylene glycol dimethacrylate) monolith and its application to simultaneous analysis of several angiotensin II receptor antagonists in human urine by capillary zone electrophoresis. J. Chromatogr. A 2006, 1102:294-301.
22. Hillaert S., van den Bossche W. Simultaneous determination of hydrochlorothiazide and several angiotensin-II-receptor antagonists by capillary electrophoresis. J. Pharm. Biomed. Anal. 2003, 31:329-339.
23. Xu M.T., Song J.F., Liang Y.D. Rapid determination of telmisartan in pharmaceutical preparations and serum by linear sweep polarography. J. Pharm. Biomed. Anal. 2004, 34:681-687.
24. Xu M.T., Song J.F., Li N. Rapid determination of telmisartan in pharmaceuticals and serum by the parallel catalytic hydrogen wave method. Anal. Bioanal. Chem. 2003, 377:1184-1189.
25. Prabhu C., Subramanian G.S., Karthik A., Kini S., Rajan M.S., Udupa N. Determination of telmisartan by HPTLC-a stability indicating assay. J. Planar Chromatogr. Mod. TLC 2007, 20:477-481.
26. European Pharmacopoeia 6.8. Supplement 6.3 2008, pp. 4325-4328.
27. ICH, Guideline Q2A, Text on validation of analytical procedures. International Conference on Harmonization, 1994, available from: http://www.ich.org/.
28. Montogomery D.C. Design and Analysis of Experiments 2007, Wiley India, New Delhi. Fifth edn.
29. Rao R.N., Maurya P.K., Ramesh M., Srinivas R., Agwane S.B. Development of a validated high-throughput LC-ESI-MS method for determination of Sirolimus on dried blood spots. Biomed. Chromatogr. 2010, 24:1356-1364.
30. Rao R.N., Maurya P.K., Shinde D.D., Khalid S. Precolumn derivatization followed by liquid chromatographic separation and determination of tramiprosate in rat plasma by fluorescence detector: Application to pharmacokinetics. J. Pharm. Biomed. Anal. 2011, 55:282-287.